Protagonist Therapeutics (PTGX) Stock Price & Financial Analysis
Protagonist Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Protagonist Therapeutics
What is the current stock price for PTGX?
As of the latest trading session, PTGX stock trades at $98.37. The 52-week range is $43.20–$107.84, with a day range of $96.69–$100.26.
What is the P/E ratio for PTGX?
The P/E ratio (Price-to-Earnings) for PTGX is shown in the Key Statistics section. This valuation metric helps compare Protagonist Therapeutics, Inc. to industry peers.
Does PTGX pay dividends?
Protagonist Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for PTGX?
Based on 9 analysts, the consensus for PTGX is Strong Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of PTGX?
Protagonist Therapeutics's market capitalization is $6.25B, classifying it as a mid-cap company. Protagonist Therapeutics operates in the Healthcare sector within the Biotechnology industry.